Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories
DeepChek®CE-IVD

DeepChek® Assay 13-Plex KB Drug Susceptibility Testing

First line, second line and new drugs

Tuberculosis (TB)

DeepChek® Assay 13-Plex KB Drug Susceptibility Testing

Specifications

End-to-end CE-IVD Solution for Mycobacterium Tuberculosis Drug Susceptibility Testing by Sequencing Suited to Small, Medium & High Throughput Laboratories

  • The DeepChek® Assay 13-Plex KB Drug Susceptibility Testing is a single multiplex polymerase chain reaction (PCR) in vitro diagnostic test intended for the amplification of relevant portions of the Mycobacterium Tuberculosis (MTB) complex DNA from unprocessed sputum specimens, concentrated sediments prepared from sputums or from MTB-positive culture.
  • Targeted Genes: